Amplitude closes debut precision medicine fund at C$200m-plus

Canadian venture capital firm Amplitude Venture Capital closed its debut precision medicine fund, securing its C$200 million target.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this